School Of Medicine At Mount Sinai Icahn is of Renalytix plc. Currently has a direct ownership of 19.3 Million shares of RNLX, which is worth approximately $2.9 Million. The most recent transaction as insider was on Apr 24, 2024, when has been sold 9,360,374 shares (Ordinary Shares) at a price of $0.25 per share, resulting in proceeds of $2,340,093. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.3M
0% 3M change
n/a 12M change
Total Value Held $2.9 Million

SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 24 2024
BUY
Other acquisition or disposition
$2,340,093 $0.25 p/Share
9,360,374 Added 32.64%
19,317,248 Ordinary Shares

Also insider at

SMFR
Sema4 Holdings Corp. Healthcare
SOM

School Of Medicine At Mount Sinai Icahn

New York, NY

Track Institutional and Insider Activities on RNLX

Follow Renalytix plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNLX shares.

Notify only if

Insider Trading

Get notified when an Renalytix PLC insider buys or sells RNLX shares.

Notify only if

News

Receive news related to Renalytix plc

Track Activities on RNLX